Biographie de John Maraganore

John était Senior Vice President, Strategic Product Development chez Millennium Pharmaceuticals, et Director of Market and Business Development chez Biogen. John Maraganore a rejoint Beam Therapeutics en 2022.

John Maraganore est actuellement

• Venture Partner at Arch Venture Partners - View - Arch Venture Partners org chart
• Board Chairman at Aera Therapeutics - View - Aera Therapeutics org chart
• Board Member at Aerium Therapeutics - View - Aerium Therapeutics org chart
• Chairman of the Board at GNS Healthcare - View - GNS Healthcare org chart
• Chairman of the Board at Orbital Therapeutics - View - Orbital Therapeutics org chart
• Director at Beam Therapeutics - View - Beam Therapeutics org chart
• Director at Chroma Medicine - View - Chroma Medicine org chart
• Director at Kymera Therapeutics - View - Kymera Therapeutics org chart
• Director at ProKidney - View - ProKidney org chart
• Director at Rapport Therapeutics - View - Rapport Therapeutics org chart
• Director at Takeda Pharmaceutical - View - Takeda Pharmaceutical org chart
• Director at Versanis Bio - View - Versanis Bio org chart

Créer une alerte
pour suivre le parcours de John Maraganore.

John Maraganore a obtenu un Master of Science in Biochemistry and Molecular Biology de University of Chicago et un PhD in Biochemistry and Molecular Biology de University of Chicago.

Ils ont aussi étudié à University of Chicago:

• Hugh Johnston - Microsoft
• Gregoire Olivier - Stellantis
• Susan Wagner - Apple

Trouver d'autres anciens étudiants de University of Chicago

Ils ont aussi étudié à University of Chicago:

• Hugh Johnston - Microsoft
• Gregoire Olivier - Stellantis
• Susan Wagner - Apple

Trouver d'autres anciens étudiants de University of Chicago

Utilisez nos services Premium/VIP pour contacter maintenant John Maraganore par email. Voici quelques conseils pour établir rapidement un excellent contact.